glp-1 drugs and alcohol consumption Weight Loss Alcohol: Why Ozempic Reduces Both GLP-1 Anti-Obesity Rx and Alcohol

How long do peptides take to show effects on bone healing

BPC-157, a 15-amino acid peptide derived from a protein in human gastric juice, exploded in popularity for its reported ability to accelerate tissue repair, reduce inflammation, and support gut healing

How the cagrilintide + retatrutide stack compares Feature Components Cagrilintide + Retatrutide Cagrilintide + Retatrutide CagriSema (Cag + Sema) Cagrilintide + Semaglutide Retatrutide Alone Retatrutide only Feature Receptor coverage Cagrilintide + Retatrutide AMY + GLP-1R + GIPR + GCGR CagriSema (Cag + Sema) AMY + GLP-1R Retatrutide Alone GLP-1R + GIPR + GCGR Feature Combination clinical data Cagrilintide + Retatrutide None (speculative) CagriSema (Cag + Sema) Phase 3 REDEFINE-1: ~22.7% at 68 weeks Retatrutide Alone Not a combination

DOI: 10.1152/japplphysiol.00945.2010

CJC-1295/Ipamorelin is a two-peptide stack acting on two different receptors (GHRH plus ghrelin) with a longer functional duration